The world’s third AIDS-free patient has been born, but the treatment is not available to ordinary patients

2022-07-28 0 By

Reporter health + | + interface According to the cable news network (CNN) reported February 16, after umbilical cord blood stem cell transplantation surgery, an American women AIDS was changed, it became the world’s no. 3 cases of AIDS improvement, and the first mixed-race woman, now its in vivo has the AIDS virus (HIV).CNN reported that the woman is a middle-aged mixed-race woman who was diagnosed with acute myeloid leukemia four years after she was diagnosed with AIDS.As part of her treatment for leukemia, she received high doses of chemotherapy.In 2017, he took stem cells from an adult relative and transplanted them into his own body to replenish his own blood cell levels.It was also treated with stem cells from cord blood from unrelated newborns, but the patient did not start producing cells until a month after the transplant.Researchers say mutations in cord blood make the cells resistant to HIV infection.More than three years after the stem cell transplant, the patient stopped taking HIV drugs and remained hiv-free 14 months after stopping the drugs.Dr. Marshall+Glesby, associate director of the Division of infectious diseases at Weill Cornell Medical College and a member of the research team, said the adult stem cells used in the first two cured cases were predominantly HIV-resistant mutations in people of Northern European ancestry, thus limiting their potential for transplantation into non-whites.But in this case, the patient was of mixed race and still had a successful transplant match, suggesting that the pool of patients available for transplantation is wider and that cord blood does not need to be as tightly matched as adult donor stem cells.However, the researchers caution that this development applies only to a small percentage of people infected with HIV.Dr. Yvonne+Bryson, chief of pediatric infectious diseases at the David Geffen School of Medicine at UCLA and the study’s lead investigator, said one man in the original study died of a recurrence of his cancer before the results could be evaluated.About 50 people a year with HIV and blood cancer could benefit from this approach.Glesby also said the treatment could lead to other health problems, up to a 20 percent chance of death.Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told CNN that the patient’s recovery may have occurred because he happened to have an underlying condition that required a stem cell transplant, but that does not mean the treatment can be used for the 36 million people living with HIV.Declaration: The copyright of this article belongs to the original author, if there is a source error or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will promptly deal with.Email address: